User:Rithish Nimmagadda: Difference between revisions
Jump to navigation
Jump to search
(9 intermediate revisions by the same user not shown) | |||
Line 22: | Line 22: | ||
==Pages Authored/Co-authored/Collaborated== | ==Pages Authored/Co-authored/Collaborated== | ||
<div style="-moz-column-count:8; column-count: | <div style="-moz-column-count:8; column-count:2;"> | ||
#[[Epcoritamab-bysp]] | #[[Epcoritamab-bysp]] | ||
Line 30: | Line 30: | ||
#[[Lotilaner]] | #[[Lotilaner]] | ||
#[[Quizartinib]] | #[[Quizartinib]] | ||
#[[Ritlecitinib]] | |||
#[[Tofersen]] | |||
#[[Retifanlimab-dlwr]] | |||
#[[Velmanase alfa-tycv]] | |||
#[[Elacestrant]] | |||
#[[Pirtobrutinib]] | |||
#[[vonoprazan, amoxicillin, and clarithromycin]] | |||
#[[Iptacopa]] |
Latest revision as of 23:19, 2 June 2024
<nowiki>
Your Name
Rithish Nimmagadda,MBBS
Research scholar
Contact:945-278-1660
Email: rithishnvs@gmail.com [1]
Current Position
- research scholar (list chapters here)
Education
Medical Degree from Kamineni Academy of Medical sciences and research centre , Hyderabad , India